Charlotte Proudhon

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Luc Cabel, Francesca Riva, Vincent Servois et al. · Annals of Oncology · 2017 · 337 citations

Life Sciences, Immunology, Oncology +17

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

Hervé Bonnefoi, Thomas Grellety, Olivier Trédan et al. · Annals of Oncology · 2016 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17

Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Francesca Riva, François‐Clément Bidard, Alexandre Houy et al. · Clinical Chemistry · 2017 · 215 citations · Full text

Medicine, Molecular Biology, Oncology +17

Protection against De Novo Methylation Is Instrumental in Maintaining Parent-of-Origin Methylation Inherited from the Gametes

Charlotte Proudhon, Rachel Duffié, Sophie Ajjan et al. · Molecular Cell · 2012 · 138 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

François‐Clément Bidard, Nicolas Kiavué, Marc Ychou et al. · Cells · 2019 · 115 citations · Full text

Medicine, Molecular Medicine, Oncology +17